Wenwen Xue

737 total citations
41 papers, 545 citations indexed

About

Wenwen Xue is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Wenwen Xue has authored 41 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 16 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Wenwen Xue's work include Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (8 papers) and Corneal surgery and disorders (8 papers). Wenwen Xue is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (8 papers) and Corneal surgery and disorders (8 papers). Wenwen Xue collaborates with scholars based in China, United States and Zambia. Wenwen Xue's co-authors include Qiang Xu, Yan Shen, Haidong Zou, Jian Gao, Minmin Fan, Yuzhu Ma, Yongqian Shu, Jingwei Chen, Xin Li and Deqiang Wang and has published in prestigious journals such as The Journal of Infectious Diseases, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Wenwen Xue

36 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenwen Xue China 13 262 184 116 96 87 41 545
Fengyan Zhang China 15 223 0.9× 94 0.5× 130 1.1× 55 0.6× 64 0.7× 44 473
Yinghong Ji China 17 309 1.2× 55 0.3× 343 3.0× 125 1.3× 172 2.0× 38 699
Fei Ji United States 11 192 0.7× 77 0.4× 101 0.9× 126 1.3× 77 0.9× 19 591
Elizabeth A. Berger United States 14 163 0.6× 60 0.3× 117 1.0× 34 0.4× 64 0.7× 35 471
Zongduan Zhang China 12 159 0.6× 49 0.3× 266 2.3× 29 0.3× 238 2.7× 47 624
Baoshan Huang China 11 139 0.5× 44 0.2× 24 0.2× 133 1.4× 56 0.6× 16 395
Ding Chen China 15 311 1.2× 47 0.3× 237 2.0× 40 0.4× 283 3.3× 32 786
Hasna Baidouri United States 13 149 0.6× 31 0.2× 116 1.0× 29 0.3× 72 0.8× 21 556
Ji Eun Kim South Korea 12 272 1.0× 91 0.5× 16 0.1× 77 0.8× 33 0.4× 23 616
Wanyu Zhang China 11 131 0.5× 58 0.3× 24 0.2× 58 0.6× 57 0.7× 46 434

Countries citing papers authored by Wenwen Xue

Since Specialization
Citations

This map shows the geographic impact of Wenwen Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwen Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwen Xue more than expected).

Fields of papers citing papers by Wenwen Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwen Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwen Xue. The network helps show where Wenwen Xue may publish in the future.

Co-authorship network of co-authors of Wenwen Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwen Xue. A scholar is included among the top collaborators of Wenwen Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwen Xue. Wenwen Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Warren, W. G., Mary Osborn, Ana David-Pereira, et al.. (2024). ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models. European Journal of Pain. 29(2). e4718–e4718. 3 indexed citations
4.
Xue, Wenwen, et al.. (2023). Deep learning-based analysis of infrared fundus photography for automated diagnosis of diabetic retinopathy with cataracts. Journal of Cataract & Refractive Surgery. 49(10). 1043–1048.
5.
Wang, Yixuan, Jian Gao, Ying Yu, et al.. (2022). A plant‐derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy. British Journal of Pharmacology. 180(2). 194–213. 10 indexed citations
7.
Xue, Wenwen, Xin Li, Yixuan Wang, et al.. (2022). Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer. Signal Transduction and Targeted Therapy. 7(1). 35–35. 17 indexed citations
8.
Fan, Minmin, Jian Gao, Lin Zhou, et al.. (2022). Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer. Acta Pharmaceutica Sinica B. 12(12). 4407–4423. 12 indexed citations
9.
Xu, Jilan, Rui-Wei Zhao, Yuejie Zhang, et al.. (2022). Cross-Field Transformer for Diabetic Retinopathy Grading on Two-field Fundus Images. 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 985–990. 6 indexed citations
10.
Xue, Wenwen, et al.. (2022). Quantitative changes in iris vasculature and blood flow in patients with different refractive errors. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(9). 3123–3129. 4 indexed citations
11.
Xue, Wenwen, et al.. (2021). Quantitative analysis and clinical application of iris circulation in ischemic retinal disease. BMC Ophthalmology. 21(1). 393–393. 7 indexed citations
12.
Xue, Wenwen, Senlin Lin, Xia Chen, et al.. (2021). In vivo Noninvasive Imaging and Quantitative Analysis of Iris Vessels. Ophthalmic Research. 64(5). 754–761. 8 indexed citations
13.
Luo, Qin, Wenwen Xue, Chaowei Fu, et al.. (2020). Peripheral anterior chamber depth and screening techniques for primary angle closure disease in community elderly Chinese. BMC Ophthalmology. 20(1). 353–353. 3 indexed citations
14.
Fan, Minmin, Jingwei Chen, Jian Gao, et al.. (2020). Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1. Cell Death and Disease. 11(8). 635–635. 26 indexed citations
15.
Xue, Wenwen & Haidong Zou. (2019). Panoramic Observation of Crystalline Lenses with 25 MHz Ultrasonography. Journal of Ophthalmology. 2019. 1–6. 3 indexed citations
16.
Xue, Wenwen, Jing You, Yingchao Su, & Qinglu Wang. (2019). The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article. Iranian Journal of Public Health. 48(3). 379–387. 24 indexed citations
17.
Ma, Yuzhu, Jingwei Chen, Bingfeng Zheng, et al.. (2019). <p>Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy</p>. International Journal of Nanomedicine. Volume 14. 8121–8132. 89 indexed citations
18.
Xue, Wenwen, Xian Xu, & Haidong Zou. (2018). A rating scale is a proper method to evaluate changes in quality of life due to dry eye symptoms. International Ophthalmology. 39(3). 563–569. 1 indexed citations
19.
Xue, Wenwen, Mingming Zhu, Bijun Zhu, et al.. (2018). Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. International Ophthalmology. 39(2). 419–429. 27 indexed citations
20.
Xue, Wenwen, Lina Lu, Xiangui He, et al.. (2016). A Cross-Sectional Population-Based Survey of Trachoma among Migrant School Aged Children in Shanghai, China. BioMed Research International. 2016. 1–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026